WePredict
Search
⌘K
Markets
Events
Leaderboards
Circles
Leagues
Suggest
Help
Login
Sign Up
Loading...
Got feedback on this market? · log in to share
Will a GLP-1 drug (Ozempic/Wegovy class) receive FDA approval for cardiovascular primary prevention in 2026? | WePredict